Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 43Sarcoma 4Lymphoid 2Other solid neoplasm 1

Conditions

Retinoblastoma 18Retinal Neoplasms 2Pediatric Solid Tumor 2Unspecified Childhood Solid Tumor, Protocol Specific 1Solid Tumors 1Solid Tumor Cancer 1Solid Tumor 1Sarcoma 1Refractory Solid Tumors in Children 1Neuroblastoma 1Mesothelioma, Malignant 1Eye Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Advanced Solid Tumor 1

Interventions

Thiotepa 5Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Etoposide 4Busulfan 4Melphalan 3Granulocyte Colony-Stimulating Factor 3Carboplatin 3Radiotherapy 2Mesna 2Ifosfamide 2Cisplatin 2sargramostim 1etoposide phosphate 1becatecarin 1Vincristine 1Ursodeoxycholic Acid 1Temozolomide 1Tamoxifen 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Methotrexate 1Leukapheresis 1Leucovorin 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Vincristine × Other solid neoplasm × Clear all
NCT00003273 2015-12-03

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NYU Langone Health

Phase 2 Withdrawn
CNSOther solid neoplasmSarcoma

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡